HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A gene expression phenotype in lymphocytes from Friedreich ataxia patients.

AbstractOBJECTIVE:
Gene expression studies in peripheral tissues from patients with neurodegenerative disorders can provide insights into disease pathogenesis, and identify potential biomarkers, an important goal of translational research in neurodegeneration. Friedreich Ataxia (FRDA) is a chronic neurodegenerative disease caused by reduced transcription of frataxin, a ubiquitously expressed protein. We studied in vitro lymphocytes from FRDA patients and carriers to identify a peripheral gene expression phenotype. Peripheral biomarkers related to disease status would be extremely valuable for assessing drug efficacy and could provide new pathophysiological insights.
METHODS:
We characterized the gene expression profiles in peripheral blood mononuclear cells (PBMCs) from FRDA patients, compared with controls and related carriers. Cells were studied both before and after in vitro treatment with compounds that increase frataxin levels. Quantitative real-time polymerase chain reaction and additional microarrays were used to confirm a core set of genes in multiple independent series.
RESULTS:
We identified a subset of genes changed in cells from patients with pathological frataxin deficiency, and a core set of these genes were confirmed in independent series. Changes in gene expression were related to the mitochondria, lipid metabolism, cell cycle, and DNA repair, consistent with FRDA's known pathophysiology. We evaluated the in vitro effect of multiple compounds (histone deacetylase inhibitors) on this putative biomarker set, and found that this biochemical phenotype was ameliorated in accordance with drug efficacy.
INTERPRETATION:
Frataxin downregulation is associated with robust changes in gene expression in PBMCs, providing pathogenetic insights and a core subset of genes that, if verified in vivo, could be used as a peripheral biomarker.
AuthorsGiovanni Coppola, Ryan Burnett, Susan Perlman, Revital Versano, Fuying Gao, Heather Plasterer, Myriam Rai, Francesco Saccá, Alessandro Filla, David R Lynch, James R Rusche, Joel M Gottesfeld, Massimo Pandolfo, Daniel H Geschwind
JournalAnnals of neurology (Ann Neurol) Vol. 70 Issue 5 Pg. 790-804 (Nov 2011) ISSN: 1531-8249 [Electronic] United States
PMID22162061 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 American Neurological Association.
Chemical References
  • Iron-Binding Proteins
Topics
  • Adult
  • Cell Culture Techniques
  • Female
  • Friedreich Ataxia (genetics, metabolism)
  • Gene Expression
  • Humans
  • Iron-Binding Proteins (drug effects, genetics)
  • Leukocytes, Mononuclear (cytology, metabolism)
  • Male
  • Phenotype
  • Real-Time Polymerase Chain Reaction
  • Frataxin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: